Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Abramson Cancer Center at Penn Medicine

8 clinical trials · 8 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Abramson Cancer Center at Penn Medicine

RECRUITINGNCT06638554

Integrating Telehealth to Advance Lung Cancer Screening

The goal of this pragmatic trial is to learn if telehealth strategies can increase shared decision-making (SDM) for lung cancer screening (LCS). It will also learn about the...

Sponsor: Abramson Cancer Center at Penn MedicineEnrolling: 60001 location
Early Detection of CancerTelemedicineDecision Making
RECRUITINGNCT05242744

FTT PET/CT in Metastatic Prostate Cancer

Up to 30 men with metastatic prostate cancer will undergo up to 2 FTT PET/CT scans to look at PARP activity in sites of known cancer. Subjects will undergo a baseline scan prior...

Sponsor: Abramson Cancer Center at Penn MedicineEnrolling: 301 location
Prostate Cancer Metastatic
RECRUITINGNCT02478892

Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk

The study is a prospective, observational study evaluating the utility of endoscopic ultrasound or MRI for the identification of preneoplastic and neoplastic pancreatic lesions in...

Sponsor: Abramson Cancer Center at Penn MedicineEnrolling: 2001 location
Pancreatic Cancer
RECRUITINGPhase 2NCT03646617

Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma

The main purpose of this study is to determine the safety of combining ipilimumab and nivolumab with hypofractionated radiotherapy to a single tumor in patients with metastatic...

Sponsor: Abramson Cancer Center at Penn MedicineEnrolling: 543 locations
Metastatic Melanoma
RECRUITINGNCT05086497

WBSI Guided Personalized Delivery of TTFields

This research study is for Glioblastoma (GBM) patients who will be beginning Optune as part of their clinical care, which is a novel treatment that utilizes - tumor treating...

Sponsor: Abramson Cancer Center at Penn MedicineEnrolling: 1552 locations
GBMGlioma Glioblastoma MultiformeTumor, Brain
RECRUITINGPhase 2NCT05932680

Limited-duration Teclistamab

This is a single-arm, non-inferiority study in which patients who have achieved a very good partial response (VGPR) or better, according to International Myeloma Working Group...

Sponsor: Abramson Cancer Center at Penn MedicineEnrolling: 755 locations
Myeloma Multiple
RECRUITINGPhase 1NCT03760575

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

The study is a single-arm phase I trial to evaluate the safety, feasibility, and preliminary efficacy of the addition of pembrolizumab and image-guided resection to surgical...

Sponsor: Abramson Cancer Center at Penn MedicineEnrolling: 201 location
Mesotheliomas Pleural
RECRUITINGNCT04367246

Li-Fraumeni Syndrome/TP53 Biobank

Li-Fraumeni Syndrome (LFS) and Li-Fraumeni-like (LFL) Syndrome are cancer predisposition syndromes due to germline aberrations in the TP53 gene. Patients with classical LFS have a...

Sponsor: Abramson Cancer Center at Penn MedicineEnrolling: 3002 locations
Li-Fraumeni SyndromeLi-Fraumeni-Like Syndrome